- Home
- TOPP vs FGEN Comparison
TOPP vs FGEN Comparison
Compare TOPP & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- FGEN
- Stock Information
- Founded
- TOPP 2014
- FGEN 1993
- Country
- TOPP United States
- FGEN United States
- Employees
- TOPP N/A
- FGEN N/A
- Industry
- TOPP
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- FGEN Health Care
- Exchange
- TOPP NYSE
- FGEN Nasdaq
- Market Cap
- TOPP 23.1M
- FGEN 33.5M
- IPO Year
- TOPP 2025
- FGEN 2014
- Fundamental
- Price
- TOPP $1.50
- FGEN $0.32
- Analyst Decision
- TOPP
- FGEN Strong Buy
- Analyst Count
- TOPP 0
- FGEN 1
- Target Price
- TOPP N/A
- FGEN $10.00
- AVG Volume (30 Days)
- TOPP 151.4K
- FGEN 521.4K
- Earning Date
- TOPP 01-01-0001
- FGEN 05-12-2025
- Dividend Yield
- TOPP N/A
- FGEN N/A
- EPS Growth
- TOPP N/A
- FGEN N/A
- EPS
- TOPP 0.01
- FGEN N/A
- Revenue
- TOPP $16,039,513.00
- FGEN $29,621,000.00
- Revenue This Year
- TOPP N/A
- FGEN $232.81
- Revenue Next Year
- TOPP N/A
- FGEN $9.16
- P/E Ratio
- TOPP $125.24
- FGEN N/A
- Revenue Growth
- TOPP N/A
- FGEN N/A
- 52 Week Low
- TOPP $0.97
- FGEN $0.18
- 52 Week High
- TOPP $4.50
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- FGEN 49.61
- Support Level
- TOPP N/A
- FGEN $0.28
- Resistance Level
- TOPP N/A
- FGEN $0.34
- Average True Range (ATR)
- TOPP 0.00
- FGEN 0.02
- MACD
- TOPP 0.00
- FGEN 0.00
- Stochastic Oscillator
- TOPP 0.00
- FGEN 53.33
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.